SC 13G

Company

Lexaria Bioscience Corp.

Filed

January 20, 2021

Accession Number

0001553350-21-000066

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →